Status:
COMPLETED
Identification of Cardiovascular Risk Factors Linked to Renal Failure Progression
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
Ministry of Health, France
Conditions:
Chronic Renal Failure
Eligibility:
All Genders
18-90 years
Brief Summary
The aim of this study is to appreciate the influence of renal failure progression on vasculopathy (coronary calcifications and left ventricular hypertrophy) and cardiovascular risk factors.
Detailed Description
The aim of this study is to appreciate the relationship between: * extension of coronary calcifications and chronic renal failure progression * extension of coronary calcifications and levels of oste...
Eligibility Criteria
Inclusion
- Patient who has signed the written consent form
- Patient aged \> 18 and \< 90 years
- Chronic renal failure defined by glomerular filtration rate (GFR)
- group 1: GFR \>90 mL/min with urinary biological abnormalities and GFR comprised between 90 and 60 mL/min
- group 2: GFR comprised between 60 and 30 mL/min
- group 3: GFR \<30 mL/min but without dialysis therapy
Exclusion
- Chronic renal failure patient requiring dialysis therapy
Key Trial Info
Start Date :
July 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00608998
Start Date
July 1 2007
End Date
October 1 2011
Last Update
March 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire
Montpellier, France, 34295